Process for obtaining intact and viable leucocytes and thrombocy

Details Process for obtaining intact and viable leucocytes and thrombocy Process for obtaining intact and viable leucocytes and thrombocy

1981-02-24

1982-08-10

Rosen, Sam

Drug, bio-affecting and body treating compositions

Fermentate of unknown chemical structure

Having a known elemental analysis

435 2, A61K 3514, A01N 102

Patent

active

043437931

ABSTRACT:
A process for obtaining functionally and morphologically intact and viable leucocytes and thrombocytes from blood is disclosed. Erythrocytes are removed from the blood and then the leucocytes are separated by centrifugation and treated to remove trace amounts of erythrocytes and thrombocytes. The thrombocytes are obtained from the supernatant produced by the centrifugation.

REFERENCES:
patent: 3709791 (1973-01-01), Lichtenstein
Tullis--Blood, vol. 7, (1952), pp. 891-896.
Boyum, A., Nature, 204: 793-794 (1964).
Day, R. P., Immunology, 18: 955-959 (1970).
Feige, U., et al., Immunobiology, 157: 217 (1980).
Graubner, M., et al., Inn. Med. 4: 316-324 (I) and 380-387 (II) (1977).
Johnson, T. M., und Garvin, J. E., Proc. Soc. Exp. Biol. Med., 102: 333-335 (1959).
Kretschmer, V., und Meuller-Eckhardt, Ch. Blut, 35: 415-418 (1977), especially the abstract.
Kretschmer, V., und Mueller-Eckhardt, Ch. Infusionstherapie, 5: 298-320 (1978), especially the abstract.
Kuramochi, T., Journal of Immunological Methods, 5: 65-69 (1974).
Loos, J. A., and Roos, D., Exp. Cell Res., 86: 333-341 (1974).
Nobel, P. P., and Cutts, J. H., J. Lab. Clin. Med., 72: 533-538 (1968).
Shortman, K., et al., J. Cell Biol., 48: 566-579 (1971).
Strelkauskas, A. J., et al., J. Immunol., 120: 1278-1282 (1978).
Thierfelder, S., Vox Sang., 9: 447-454 (1964).
Ting, A. & Morris, P. J., Vox Sang, 20: 561-563 (1971).
Thorsby, E. & Bratlie, A., Histocompatibility Testing 1970 (ed. P. I. Terasaki), pp. 655-656, Munksgaard, Copenhagen 1970.
v. Heyden, H. W., Proc. Soc. Exp. Biol. Med., 139: 1181-1184 (1972).
Nyegaard & Co. AS, Oslo Sodium Metrizoate Solution for Isolation of Blood Cells., A/S Stjerne-Trykk, Nr. 746-75.
Pharmacia Fine Chemicals AB, Uppsala: Ficoll for cell research. Sven Hallberg Reklam/Upplands Grafiska AB, Mar. 1973-1976.
Pharmacia Fine Chemicals AB, Uppsala: Dextran Fractions, dextran sulfate, DEAE-dextran. Defined polymers for biological research. Upplands Grafiska AB, Dec. 1974-1975.

Affiliated with

Also associated with

Rating

Process for obtaining intact and viable leucocytes and thrombocy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for obtaining intact and viable leucocytes and thrombocy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for obtaining intact and viable leucocytes and thrombocy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1531096